Mouth cancer
A study comparing low-dose oral chemotherapy with standard doctor-selected treatment in patients with advanced prostate cancer that has spread and no longer responds to hormone therapy.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Registry summary (technical)
Cyclophosphamide Dexamethasone as Metronomic Chemotherapy Versus Physician choice Therapy for Metastatic Castrate Resistant Prostate Cancer: A randomized , open label Phase III study (CYCLONE-PRO Study) - NIL
Sponsor: Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC)
CTRI/2026/02/103234 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026